-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901.O1.6 901. Health Services and Outcomes Research – Non-Malignant Conditions: Venous Thromboembolism in Malignancy

Health Services and Outcomes Research – Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Oral
Monday, December 7, 2015: 10:30 AM-12:00 PM
W304ABCD, Level 3 (Orange County Convention Center)
Moderators:
Neil A Zakai, MD, MSc, University of Vermont and Marc Carrier, M.D., MSc, FRCPC, Ottawa Hospital Research Institute

Disclosures:
Carrier: Bayer: Consultancy ; Pfizer: Consultancy ; Leo Pharma: Research Funding ; BMS: Research Funding .
10:30 AM

Ryma Ihaddadene, BHSc, MSc1,2*, Daniel J Corsi, PhD2*, Alejandro Lazo-Langner, MD3,4*, Sudeep Shivakumar, MD5,6, Vicky Tagalakis, MD, MSc7,8, Ryan Zarychanski, MD, MSc9,10*, Susan Solymoss, MD11,12, Nathalie Routhier, MD13,14*, James D. Douketis, MD15,16* and Marc Carrier, MD, MSc1,2,17

1Department of Medicine, University of Ottawa, Ottawa, ON, Canada
2Ottawa Hospital Research Institute, Ottawa, ON, Canada
3Department of Medicine, University of Western Ontario, London, ON, Canada
4Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada
5Department of Hematology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
6Department of Medicine, Dalhousie University, Halifax, NS, Canada
7Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, Montreal, QC, Canada
8Center for Clinical Epidemiology, Lady Davis Institute, Montreal, QC, Canada
9Department of Medicine, University of Manitoba, Winnipeg, MB, Canada
10Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, MB, Canada
11Department of Medicine, McGill University, Montreal, QC, Canada
12Division of Hematology, Montreal General Hospital and St. Mary's Hospital, Montreal, QC, Canada
13Department of Medicine, Université de Montréal, Montreal, QC, Canada
14Sacre Coeur Hospital, Montreal, QC, Canada
15St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada
16Department of Medicine, McMaster University, Hamilton, ON, Canada
17Ottawa Hospital General Campus, Ottawa, ON, Canada

10:45 AM

Alok A. Khorana, MD1, Keith McCrae1, Dejan Milentijevic2*, Jonathan Fortier3*, Winnie Nelson2*, François Laliberté3*, Concetta Crivera2*, Patrick Lefebvre3*, Daniel Yannicelli4* and Jeff Schein2*

1Cleveland Clinic, Cleveland, OH
2Janssen Scientific Affairs, LLC, Raritan, NJ
3Groupe d’analyse, Ltée, Montréal, QC, Canada
4Janssen Pharmaceuticals, Inc., Raritan, NJ

11:00 AM

Dana E Angelini, MD1, Todd Greene, PhD, MPH2*, Julie N Wietzke, MHSA, MLS2*, Scott A Flanders, MD2* and Suman L. Sood, MD1

1Department of Medicine; Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
2Department of Medicine, University of Michigan, Ann Arbor, MI

11:15 AM

Inger Lise Gade, MD1*, Sigrid K Brækkan2,3*, Inger Anne Næss, MD4*, John-Bjarne Hansen, MD2,3*, Frits Rosendaal, MD5, Suzanne C Cannegieter, MD5*, Kim Overvad, MD6,7*, Hilde Jensvoll, MD2,3*, Jens Hammerstrøm, MD8*, Kristine Blix, MD2,3*, Anne Tjønneland, MD9*, Søren R Kristensen, MD10,11* and Marianne Tang Severinsen1,11*

1Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
2K.G. Jebsen Thrombosis Research and Expertice Centre (TREC), UiT The Arctic University of Norway, Tromsø, Norway
3Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
4Department of Hematology, Trondheim University Hospital, Trondheim, Norway
5Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands
6Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark
7Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark
8Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway
9Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark
10Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
11Department of Clinical Medicine, Aalborg University Hospital, Aalborg, Denmark

11:30 AM

Raminder Chadha, MS41*, Ruchika Goel, MD, MPH2* and Clifford M. Takemoto, MD1

1Division of Pediatric Hematology, The Johns Hopkins University, Baltimore, MD
2Department of Pathology and Laboratory Medicine, Weill Cornell Medical College/ New York Presbyterian Hospital, New York, NY

11:45 AM

Kathan Dilipbhai Mehta, MBBS, MPH1, Sameer A. Parikh, MD2, Hong Wang, PhD3*, Rahul Atul Parikh, MD, PhD3* and Roy E. Smith, MD4

1University of Pittsburgh Medical Center, Pittsburgh, PA
2Division of Hematology, Mayo Clinic, Rochester, MN
3University of Pittsburgh, Pittsburgh, PA
4Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA

*signifies non-member of ASH